Dr Ula: Normal doesn’t mean at capacity. Here’s the difference.

You’ve had the bloods done. You hear the words you were hoping to hear — everything looks normal. And on the way home you tried to feel reassured, because that’s what the result is supposed to do.

By Wednesday afternoon, you were back where you started. The 3pm flatness. The second coffee that didn’t work. The week at the gym that felt twice as heavy as it did three years ago. The mental sharpness that used to be the easiest thing you owned, now something you struggle to find.

Nothing on the panel explains it. And yet the gap between how you’re operating and how you know you can operate is real, and it has not closed on its own.

This is the thing the standard panel was not designed to answer.

What “normal” actually means

A standard blood panel is a disease-detection instrument. It is calibrated to find the markers that indicate something has gone clinically wrong, blood sugar in the diabetic range, cholesterol high enough to warrant statins, thyroid function outside the reference interval. When those markers sit inside the boundaries, the panel returns normal and that result is doing exactly what it was designed to do.

What it is not designed to do is tell you whether your system is running at its biological capacity. Those are two different questions. The first asks: do you have a disease? The second asks: is your biology performing the way it can perform when nothing is dragging on it? The standard panel answers the first one. It is not built to answer the second.

This is not a system failure. It is a scope question. The standard panel was never asked the question you are now asking.

What sits in the gap

The gap between “no disease” and “biological capacity” is where most of the patients we see have been living. And it is rarely empty. The most common things that occupy it are mechanisms that sit just below the thresholds a standard panel is set to detect.

Chronic stress running as a steady background load. A single morning cortisol reading can look fine while the rhythm of cortisol across the day — high at the right time, low at the right time, dropping in a clean curve — is meaningfully disrupted. The rhythm is what governs energy, focus, and recovery. Without measuring it at four points across the day, the disruption stays invisible.

Metabolic dysregulation that hasn’t yet shifted glucose. Fasting insulin is the test that shows insulin resistance forming, sometimes years before glucose moves enough to register as pre-diabetic. It is not on the standard panel.

Chronic low-grade systemic inflammation. HsCRP is a marker of the kind of inflammation that doesn’t necessarily hurt or show but quietly elevates cardiovascular risk and drags on energy and recovery in the background. It's invisible. Not because it couldn’t be measured, because it wasn’t being measured.

None of these mechanisms are exotic. None of them require unusual technology to find. They simply sit outside the scope of the panel that was run.

What investigation looks like

When someone comes to us with the experience of “nothing wrong, still not right,” the first step is to stop reading the standard panel as if it were the comprehensive one. It isn’t. We measure the things it wasn’t asked to measure, and we read them as a pattern, because patterns across markers carry information that single markers in isolation never can. A cortisol rhythm that has flattened, a fasting insulin sitting at the upper end of normal, an HsCRP elevated against an otherwise unremarkable lipid picture: each one is suggestive on its own. Together they describe a system that is compensating for something it shouldn’t have to.

Investigation precedes recommendation. We find out what is generating the gap before we make any decisions about what to do with it. That sequence is the thing that distinguishes this work from the conversation you’ve already had.

A sensible next step

If your standard bloods have ruled out disease, that is genuinely useful information. It is also where most clinical investigation stops, and where the question you came in with often hasn’t been answered.

The standard panel did its job. The question is whether the question it was answering is the question you are actually asking.

Dr. Ula

Co-Founder and Lead Physician, Autonomy

 Book a Discovery Consultation today!

Our Discovery Consultation is a one hour session with our clinical team.  It is the conversation where we look at what has already been investigated, what hasn’t, and whether further investigation is warranted for the specific picture you are describing. You leave knowing what would be measured next, and why, and whether it would change anything you can act on.

BOOK NOW